China SXT Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

China SXT Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $18.10 million for the year ending 2025.

  • China SXT Pharmaceuticals, Inc. showed an increase of +49.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
  • XBRL data for this metric is available from 2016 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2016 to 2025), China SXT Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 158,122.0%.
  • Historical annual values: Fiscal year 2025: $18.10 million | Fiscal year 2024: $12.07 million | Fiscal year 2023: $17.37 million | Fiscal year 2021: $13.36 million | Fiscal year 2020: $7.29 million | Fiscal year 2019: $9.29 million | Fiscal year 2018: $657.8 thousand | Fiscal year 2017: $65.6 thousand | Fiscal year 2016: $11.4 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: